Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

XRISE-M: X-radiography facility for solidification and diffusion studies of alloys aboard sounding rockets.

The Review of scientific instruments·2020
Same author

ARTEC-A furnace module for directional solidification and quenching experiments in microgravity.

The Review of scientific instruments·2020
Same author

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Canadian respiratory journal·2012
Same author

Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2011
Same author

Limestone concretions at the ends of the fingers.

Annales de dermatologie et de syphiligraphie·2010
Same author

Management of chronic bronchitis and acute exacerbations of chronic bronchitis.

International journal of antimicrobial agents·2008

相关实验视频

Updated: Jul 20, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

疟疾. 疟疾. 世卫组织可以逆转疟疾吗?

M Balter

    Science (New York, N.Y.)
    |February 24, 2001
    PubMed
    概括

    世界卫生组织于1998年推出了Roll Back Malaria,旨在在十年内将疟疾死亡人数减少一半. 专家们认为这个雄心勃勃的目标是可以实现的,尽管有些人质疑它的可行性.

    科学领域:

    • 全球卫生倡议 全球卫生倡议
    • 传染病控制 传染病控制
    • 公共卫生政策 公共卫生政策

    背景情况:

    • 世界卫生组织 (WHO) 于1998年10月发起了"逆转疟疾"运动.
    • 主要目标是在十年内将全球疟疾死亡率降低50%.

    更多相关视频

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024

    相关实验视频

    Last Updated: Jul 20, 2026

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
    13:48

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

    Published on: June 24, 2012

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024